| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Ank_2 | SHANK1 ANKRD31 ANKRD20A2P ANKRD20A3P ANKRD36B ANKRD20A4P ANKRD18A HECTD1 ANKRD20A1 | 3.38e-05 | 215 | 139 | 9 | PF12796 |
| Domain | Ank | SHANK1 ANKRD31 ANKRD20A2P ANKRD20A3P ANKRD36B ANKRD20A4P ANKRD18A HECTD1 ANKRD20A1 | 5.33e-05 | 228 | 139 | 9 | PF00023 |
| Domain | - | SHANK1 ANKRD31 ANKRD20A2P ANKRD20A3P ANKRD36B ANKRD20A4P ANKRD18A HECTD1 ANKRD20A1 | 1.02e-04 | 248 | 139 | 9 | 1.25.40.20 |
| Domain | ANK | SHANK1 ANKRD31 ANKRD20A2P ANKRD20A3P ANKRD36B ANKRD20A4P ANKRD18A HECTD1 ANKRD20A1 | 1.11e-04 | 251 | 139 | 9 | SM00248 |
| Domain | ANK_REPEAT | SHANK1 ANKRD31 ANKRD20A2P ANKRD20A3P ANKRD36B ANKRD20A4P ANKRD18A HECTD1 ANKRD20A1 | 1.18e-04 | 253 | 139 | 9 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | SHANK1 ANKRD31 ANKRD20A2P ANKRD20A3P ANKRD36B ANKRD20A4P ANKRD18A HECTD1 ANKRD20A1 | 1.22e-04 | 254 | 139 | 9 | IPR020683 |
| Domain | ANK_REP_REGION | SHANK1 ANKRD31 ANKRD20A2P ANKRD20A3P ANKRD36B ANKRD20A4P ANKRD18A HECTD1 ANKRD20A1 | 1.22e-04 | 254 | 139 | 9 | PS50297 |
| Domain | Ankyrin_rpt | SHANK1 ANKRD31 ANKRD20A2P ANKRD20A3P ANKRD36B ANKRD20A4P ANKRD18A HECTD1 ANKRD20A1 | 1.54e-04 | 262 | 139 | 9 | IPR002110 |
| Domain | MYB_LIKE | 1.78e-04 | 38 | 139 | 4 | PS50090 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 7.82e-05 | 13 | 94 | 3 | MM15363 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 7.82e-05 | 13 | 94 | 3 | M27661 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LESION_BYPASS_BY_TLS_AND_DSB_FORMATION | 1.23e-04 | 15 | 94 | 3 | M47854 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN | 2.18e-04 | 18 | 94 | 3 | MM15336 | |
| Pubmed | SHANK1 NPM1 MIA3 ARHGAP24 ZEB1 UBAP2 MYCBP2 CENPF TBC1D5 APC HUWE1 ITIH4 AKAP12 HOOK3 CSNK1A1L DST ATXN2 SYNE2 YLPM1 SUPT16H GIGYF2 LRRC7 QSER1 SEPTIN7 NIPBL EPB41L2 | 3.00e-14 | 963 | 144 | 26 | 28671696 | |
| Pubmed | NPM1 SRSF4 MYCBP2 CENPF NSD2 URB2 HUWE1 RBM28 IGF2BP3 DST SUGP2 NSA2 SYNE2 YLPM1 OASL GIGYF2 PDS5A HECTD1 NIPBL EPB41L2 | 3.85e-12 | 653 | 144 | 20 | 22586326 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NPM1 NUP50 NCOA6 HIVEP1 SETX UBAP2 SRSF4 BAZ2B ATAD5 NSD2 RBM28 RRBP1 MTA1 SUGP2 ATXN2 SLF2 YLPM1 SUPT16H GIGYF2 PDS5A QSER1 SEPTIN7 NIPBL | 1.06e-11 | 954 | 144 | 23 | 36373674 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NPM1 NUP50 NCOA6 EME1 SETX SRSF4 CENPF CTDSPL2 BAZ2B ATAD5 NSD2 RBM28 RRBP1 KIF20A RALY MTA1 DST INTS2 SLF2 YLPM1 SUPT16H PDS5A NKTR QSER1 NIPBL | 1.35e-10 | 1294 | 144 | 25 | 30804502 |
| Pubmed | NPM1 SETX BMP2K APBB2 APC HUWE1 FAM171B AKAP12 KIF20A IGF2BP3 LIPE DST SUGP2 PDS5A ZFHX3 WDR41 AKAP1 SDK1 EPB41L2 | 6.15e-10 | 777 | 144 | 19 | 35844135 | |
| Pubmed | SHANK1 OXR1 MYCBP2 APBB2 APC HUWE1 REV3L RRBP1 LRP1B FAN1 MTA1 DST ZNF532 SLF2 MTIF2 YLPM1 USP32 CCDC15 ZNF83 SEPTIN7 HECTD1 NIPBL CNOT2 ZNF292 | 6.52e-10 | 1285 | 144 | 24 | 35914814 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | UBAP2 BMP2K MYCBP2 ATAD5 CNOT10 RC3H1 APC RRBP1 AKAP12 KIF20A IGF2BP3 MTA1 SUGP2 ATXN2 CPEB4 YLPM1 GIGYF2 ZNF292 | 1.39e-09 | 724 | 144 | 18 | 36232890 |
| Pubmed | GABRB1 SHANK1 NPM1 MIA3 UBAP2 FRMPD4 MYCBP2 APC TACC2 HUWE1 IDH3G FAM171B RRBP1 LRP1B RALY SUGP2 IGHMBP2 CPEB4 LRRC7 SEPTIN7 CNOT2 EPB41L2 | 1.98e-09 | 1139 | 144 | 22 | 36417873 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NCOA6 UAP1 HIVEP1 SETX UBAP2 MYCBP2 TBC1D5 APC RGS12 DST SLF2 STARD9 SYNE2 COBL GIGYF2 PATJ AKAP1 HECTD1 EPB41L2 | 3.30e-09 | 861 | 144 | 19 | 36931259 |
| Pubmed | DMTF1 MIA3 SETX GBP7 BMP2K AKNAD1 APC TACC2 HUWE1 RBM28 FAM171B ITGB4 AKAP12 MTA1 INTS2 VILL NSA2 QSER1 SEC63 PATJ CNOT2 | 4.56e-09 | 1084 | 144 | 21 | 11544199 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | HIVEP1 SETX CTDSPL2 BAZ2B ATAD5 NSD2 MYSM1 KIF20A MTA1 NKX2-1 SUPT16H PDS5A QSER1 NIPBL ZHX1 ZNF292 | 5.47e-09 | 608 | 144 | 16 | 36089195 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NPM1 MYCBP2 CENPF ATAD5 NSD2 TACC2 URB2 RBM28 RRBP1 RALY IGF2BP3 SUGP2 NSA2 IGHMBP2 SUPT16H AKAP1 HECTD1 | 1.90e-08 | 759 | 144 | 17 | 35915203 |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 1.95e-08 | 8 | 144 | 4 | 12634303 | |
| Pubmed | NCOA6 ZEB1 HIVEP1 UBAP2 ATAD5 CNOT10 RC3H1 RBM28 IGF2BP3 MTA1 DST SUGP2 ATXN2 NSA2 SYNE2 YLPM1 GIGYF2 PDS5A ZFHX3 QSER1 NIPBL ZHX1 CNOT2 | 2.48e-08 | 1429 | 144 | 23 | 35140242 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | NPM1 MIA3 UBAP2 MYCBP2 APC HUWE1 RBM28 RRBP1 KIF20A YLPM1 SUPT16H NKTR HECTD1 | 4.19e-08 | 440 | 144 | 13 | 34244565 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NPM1 MYCBP2 CENPF HAUS5 URB2 HUWE1 RBM28 RRBP1 RALY IGF2BP3 HOOK3 DST SUGP2 SYNE2 YLPM1 SUPT16H GIGYF2 NIPBL EPB41L2 | 5.22e-08 | 1024 | 144 | 19 | 24711643 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MIA3 SRSF4 BMP2K MYCBP2 CENPF GPAM TACC2 HUWE1 RBM28 NAA50 RRBP1 RALY IGF2BP3 DST ATXN2 NSA2 MTIF2 SYNE2 SUPT16H ALAS1 WDR41 SEC63 AKAP1 | 5.69e-08 | 1496 | 144 | 23 | 32877691 |
| Pubmed | SETX BMP2K ATAD5 NSD2 CNOT10 APC URB2 CRACD MTA1 DST INTS2 ATXN2 NSA2 IGHMBP2 PDS5A ZFHX3 SEC63 PATJ AKAP1 NIPBL ZHX1 CNOT2 EPB41L2 | 5.76e-08 | 1497 | 144 | 23 | 31527615 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | NUP50 CENPF CNOT10 HAUS5 APC TACC2 NAA50 RRBP1 AKAP12 KIF20A RALY FANCB IGF2BP3 CSNK1A1L PER3 YLPM1 CCDC15 PDS5A NIPBL CNOT2 | 6.93e-08 | 1155 | 144 | 20 | 20360068 |
| Pubmed | MIA3 UBAP2 MYCBP2 APC HUWE1 RBM28 RRBP1 RALY YLPM1 WDR41 QSER1 SEC63 PATJ AKAP1 HECTD1 CNOT2 | 7.27e-08 | 733 | 144 | 16 | 34672954 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | SETX CENPF BAZ2B GPAM ANKRD20A3P HUWE1 RBM28 REV3L FREM2 IGF2BP3 AFAP1L2 DST PDS5A ANKRD18A LRRC7 EPB41L2 | 7.69e-08 | 736 | 144 | 16 | 29676528 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 MIA3 MYCBP2 NSD2 TBC1D5 RDH10 APBB2 HUWE1 RRBP1 RALY SUGP2 INTS2 ZNF532 ATXN2 COBL ZFHX3 LUZP2 LRRC7 QSER1 DENND5A PATJ HECTD1 | 2.26e-07 | 1489 | 144 | 22 | 28611215 |
| Pubmed | 3.41e-07 | 285 | 144 | 10 | 34369648 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NPM1 NUP50 UBAP2 ATAD5 TBC1D5 TACC2 RRBP1 AKAP12 CRACD IGF2BP3 DST SUGP2 YLPM1 GIGYF2 AKAP1 NIPBL EPB41L2 | 3.63e-07 | 934 | 144 | 17 | 33916271 |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | GABRB1 SHANK1 SRSF4 MYCBP2 RALYL RRBP1 IGF2BP3 SUGP2 ATXN2 CPEB4 YLPM1 AKAP1 | 5.58e-07 | 462 | 144 | 12 | 31138677 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NPM1 SETX SRSF4 MYCBP2 NSD2 APC RALY IGF2BP3 DST SUGP2 ZNF532 CPEB4 YLPM1 SUPT16H PDS5A SEC63 NIPBL ZNF292 | 5.91e-07 | 1082 | 144 | 18 | 38697112 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA6 EME1 ZEB1 HIVEP1 MYCBP2 HUWE1 RRBP1 MTA1 SUGP2 YLPM1 GIGYF2 AKAP1 NIPBL ZHX1 EPB41L2 | 8.52e-07 | 774 | 144 | 15 | 15302935 |
| Pubmed | SHANK1 HIVEP1 SETX APC ITGB4 DST COBL GIGYF2 NKTR ZNF83 ZHX1 EPB41L2 | 9.49e-07 | 486 | 144 | 12 | 20936779 | |
| Pubmed | NUP50 SETX CENPF APC TACC2 HUWE1 RRBP1 ITGB4 MTA1 HOOK3 NIPBL EPB41L2 | 1.36e-06 | 503 | 144 | 12 | 16964243 | |
| Pubmed | TBC1D5 APBB2 RRBP1 TMEM87A AKAP12 DST ZFYVE9 SYNE2 USP32 WDR41 SEC63 AKAP1 | 1.38e-06 | 504 | 144 | 12 | 34432599 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | NPM1 SRSF4 RC3H1 RBM28 RRBP1 RALY IGF2BP3 SUGP2 ATXN2 NSA2 CPEB4 YLPM1 SUPT16H GIGYF2 AKAP1 | 1.43e-06 | 807 | 144 | 15 | 22681889 |
| Pubmed | ZEB1 HIVEP1 MYCBP2 CENPF APC HUWE1 DST ZNF532 GIGYF2 ZFHX3 AKAP1 | 1.48e-06 | 418 | 144 | 11 | 34709266 | |
| Pubmed | NPM1 NUP50 MIA3 SETX MYCBP2 APC URB2 RRBP1 AKAP12 IGF2BP3 DST SYNE2 PDS5A SEPTIN7 SEC63 AKAP1 HECTD1 NIPBL EPB41L2 | 1.86e-06 | 1297 | 144 | 19 | 33545068 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | DMTF1 NCOA6 UBAP2 CTDSPL2 TBC1D5 MTA1 ZNF532 ATXN2 YLPM1 PATJ ZHX1 | 1.95e-06 | 430 | 144 | 11 | 35044719 |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 2.13e-06 | 349 | 144 | 10 | 25665578 | |
| Pubmed | 2.31e-06 | 274 | 144 | 9 | 34244482 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 3.00e-06 | 283 | 144 | 9 | 30585729 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 3.09e-06 | 212 | 144 | 8 | 33853758 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | UBAP2 CNOT10 RBM28 MYSM1 RALY IGF2BP3 ATXN2 YLPM1 HECTD1 CNOT2 | 3.09e-06 | 364 | 144 | 10 | 24778252 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | NUP50 UBAP2 MYCBP2 CENPF NSD2 HS6ST2 URB2 RBM28 SUGP2 INTS2 MTIF2 IGHMBP2 GIGYF2 HECTD1 | 3.30e-06 | 754 | 144 | 14 | 33060197 |
| Pubmed | MIA3 SETX TBC1D5 APC GPAM RRBP1 FREM2 DST MTIF2 GIGYF2 QSER1 DENND5A PATJ | 3.39e-06 | 650 | 144 | 13 | 38777146 | |
| Pubmed | NPM1 SETX UBAP2 RDH10 RBM28 RRBP1 RALY ANKRD36B IGF2BP3 SUGP2 ATXN2 NSA2 STARD9 CPEB4 YLPM1 SUPT16H NKTR SEC63 EPB41L2 | 4.15e-06 | 1371 | 144 | 19 | 36244648 | |
| Pubmed | 5.81e-06 | 107 | 144 | 6 | 30995489 | ||
| Pubmed | DMTF1 NCOA6 HIVEP1 MYCBP2 PSG5 HUWE1 RRBP1 DST ZFYVE9 YLPM1 ZNF83 SDK1 | 7.03e-06 | 591 | 144 | 12 | 15231748 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 7.38e-06 | 170 | 144 | 7 | 23314748 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BDP1 ZNF211 CENPF RRBP1 TMEM87A RGS12 IGHMBP2 USP32 COBL GIGYF2 ZNF292 | 7.71e-06 | 497 | 144 | 11 | 36774506 |
| Pubmed | NUP50 MIA3 MYCBP2 CTDSPL2 ATAD5 NSD2 TBC1D5 HUWE1 NAA50 FAM171B FAN1 ZFYVE9 ATXN2 SYNE2 YLPM1 SUPT16H | 7.81e-06 | 1049 | 144 | 16 | 27880917 | |
| Pubmed | NPM1 APC NAA50 RRBP1 AKAP12 DST GIGYF2 PDS5A LRRC7 SEPTIN7 SEC63 PATJ EPB41L2 | 8.47e-06 | 708 | 144 | 13 | 39231216 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 1.34e-05 | 259 | 144 | 8 | 30404004 | |
| Pubmed | NUP50 NCOA6 HIVEP1 SETX MYCBP2 BAZ2B RBM28 NAA50 IGF2BP3 MTA1 SUGP2 ATXN2 PDS5A QSER1 NIPBL ZNF292 | 1.45e-05 | 1103 | 144 | 16 | 34189442 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | TACC2 NAA50 IGF2BP3 MTA1 SUGP2 USP32 ZFHX3 HECTD1 NIPBL CNOT2 EPB41L2 | 1.56e-05 | 536 | 144 | 11 | 15840001 |
| Pubmed | 1.57e-05 | 191 | 144 | 7 | 31177093 | ||
| Pubmed | TACC2 NAA50 IGF2BP3 MTA1 SUGP2 USP32 ZFHX3 HECTD1 NIPBL CNOT2 EPB41L2 | 1.61e-05 | 538 | 144 | 11 | 10512203 | |
| Pubmed | NPM1 ABCA12 ATAD5 NSD2 HAUS5 RALYL REV3L ITIH4 KIF20A RALY MTA1 SUGP2 MTIF2 CPEB4 SUPT16H ZFHX3 | 1.67e-05 | 1116 | 144 | 16 | 31753913 | |
| Pubmed | Sidekick-1 is upregulated in glomeruli in HIV-associated nephropathy. | 1.70e-05 | 2 | 144 | 2 | 15213259 | |
| Pubmed | Definition of the critical domains required for homophilic targeting of mouse sidekick molecules. | 1.70e-05 | 2 | 144 | 2 | 15703275 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 30150416 | ||
| Pubmed | Efficient DNA binding of NF-κB requires the chaperone-like function of NPM1. | 1.70e-05 | 2 | 144 | 2 | 28003476 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 31813992 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 31006587 | ||
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 35490918 | ||
| Pubmed | Significance of IMP3, nucleophosmin, and Ki-67 expression in papillary thyroid carcinoma. | 1.70e-05 | 2 | 144 | 2 | 25389240 | |
| Pubmed | KIF20A-mediated RNA granule transport system promotes the invasiveness of pancreatic cancer cells. | 1.70e-05 | 2 | 144 | 2 | 25499221 | |
| Pubmed | 1.70e-05 | 2 | 144 | 2 | 22994768 | ||
| Pubmed | Sidekicks: synaptic adhesion molecules that promote lamina-specific connectivity in the retina. | 1.70e-05 | 2 | 144 | 2 | 12230981 | |
| Pubmed | RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2. | 1.70e-05 | 2 | 144 | 2 | 33750796 | |
| Pubmed | Molecular basis of sidekick-mediated cell-cell adhesion and specificity. | 1.70e-05 | 2 | 144 | 2 | 27644106 | |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 1.97e-05 | 358 | 144 | 9 | 32460013 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 2.10e-05 | 361 | 144 | 9 | 30344098 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NPM1 NUP50 HIVEP1 CENPF NSD2 URB2 HUWE1 IDH3G RRBP1 RALY STARD9 SUPT16H GIGYF2 PDS5A SEPTIN7 SEC63 NIPBL EPB41L2 | 2.61e-05 | 1425 | 144 | 18 | 30948266 |
| Pubmed | MIA3 TBC1D5 RRBP1 TMEM87A AKAP12 DST SYNE2 GIGYF2 WDR41 SEC63 AKAP1 | 2.65e-05 | 568 | 144 | 11 | 37774976 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | NPM1 SRSF4 CNOT10 RC3H1 RBM28 IGF2BP3 SUGP2 ATXN2 SUPT16H GIGYF2 QSER1 CNOT2 | 2.73e-05 | 678 | 144 | 12 | 30209976 |
| Pubmed | 2.80e-05 | 209 | 144 | 7 | 36779422 | ||
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 2.83e-05 | 375 | 144 | 9 | 32788342 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 2.93e-05 | 289 | 144 | 8 | 23752268 | |
| Pubmed | 3.04e-05 | 143 | 144 | 6 | 32560809 | ||
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 3.63e-05 | 298 | 144 | 8 | 32353859 | |
| Pubmed | 3.83e-05 | 149 | 144 | 6 | 25184681 | ||
| Pubmed | ATRX proximal protein associations boast roles beyond histone deposition. | 3.96e-05 | 91 | 144 | 5 | 34780483 | |
| Pubmed | 4.12e-05 | 222 | 144 | 7 | 37071664 | ||
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 4.18e-05 | 92 | 144 | 5 | 15840729 | |
| Pubmed | NPM1 UBAP2 CENPF AKAP12 KIF20A RALY IGF2BP3 SUPT16H PDS5A SEPTIN7 | 4.30e-05 | 494 | 144 | 10 | 26831064 | |
| Pubmed | MIA3 SRSF4 OXR1 NAA50 RRBP1 TMEM87A AKAP12 RALY CSNK1A1L NSA2 USP32 WDR41 SEC63 EPB41L2 | 4.42e-05 | 952 | 144 | 14 | 38569033 | |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 4.67e-05 | 400 | 144 | 9 | 35013556 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NPM1 SETX MYCBP2 URB2 HUWE1 RBM28 NAA50 RRBP1 KIF20A RALY DST SUGP2 NSA2 SUPT16H PDS5A NIPBL EPB41L2 | 4.75e-05 | 1353 | 144 | 17 | 29467282 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | TBC1D5 RDH10 APC URB2 IDH3G TMEM87A RGS12 AKAP12 AFAP1L2 HOOK3 OASL COBL | 4.81e-05 | 719 | 144 | 12 | 35337019 |
| Pubmed | 4.87e-05 | 228 | 144 | 7 | 30471916 | ||
| Pubmed | DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). | 5.09e-05 | 3 | 144 | 2 | 15106121 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 20729552 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 25337222 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 36172730 | ||
| Pubmed | E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling. | 5.09e-05 | 3 | 144 | 2 | 28137882 | |
| Pubmed | Role of casein kinase 1A1 in the biology and targeted therapy of del(5q) MDS. | 5.09e-05 | 3 | 144 | 2 | 25242043 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 28655862 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 35230972 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 22080605 | ||
| Pubmed | Zinc finger protein 277 is an intestinal transit-amplifying cell marker and colon cancer oncogene. | 5.09e-05 | 3 | 144 | 2 | 35015732 | |
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 30314706 | ||
| Pubmed | 5.09e-05 | 3 | 144 | 2 | 26586120 | ||
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | 5.65e-05 | 410 | 144 | 9 | 26949251 | |
| Interaction | NUP43 interactions | NPM1 NUP50 NCOA6 EME1 HIVEP1 SETX BAZ2B NSD2 APC RBM28 MYSM1 MTA1 DST ZNF532 SLF2 NKX2-1 SYNE2 SUPT16H ZFHX3 NKTR NIPBL ZHX1 ZNF292 | 6.90e-11 | 625 | 141 | 23 | int:NUP43 |
| Interaction | LARP4B interactions | NPM1 UBAP2 NSD2 RC3H1 KIF20A RALY IGF2BP3 SUGP2 ATXN2 CPEB4 OASL AKAP1 HECTD1 | 1.44e-08 | 240 | 141 | 13 | int:LARP4B |
| Interaction | SMC5 interactions | NPM1 NUP50 NCOA6 HIVEP1 SETX UBAP2 SRSF4 BAZ2B ATAD5 NSD2 RBM28 REV3L RRBP1 MTA1 SUGP2 ATXN2 SLF2 YLPM1 SUPT16H GIGYF2 PDS5A QSER1 SEPTIN7 HECTD1 NIPBL | 2.67e-08 | 1000 | 141 | 25 | int:SMC5 |
| Interaction | SNRNP40 interactions | NPM1 HIVEP1 SETX BAZ2B ATAD5 NSD2 RC3H1 RBM28 MYSM1 KIF20A RALY MTA1 SUGP2 ZNF532 SUPT16H ZFHX3 NKTR HECTD1 EPB41L2 | 1.04e-07 | 637 | 141 | 19 | int:SNRNP40 |
| Interaction | PARP1 interactions | NPM1 NCOA6 ARHGAP24 ZEB1 HIVEP1 UBAP2 MYCBP2 CTDSPL2 ATAD5 NSD2 RC3H1 URB2 HUWE1 RBM28 MYSM1 KIF20A MTA1 NKX2-1 NSA2 STARD9 MTIF2 SUPT16H PDS5A ZNF83 HECTD1 NIPBL EPB41L2 ZNF292 | 1.06e-07 | 1316 | 141 | 28 | int:PARP1 |
| Interaction | DDX21 interactions | NPM1 ARHGAP24 ZEB1 SRSF4 NSD2 RC3H1 APC URB2 HUWE1 RBM28 KIF20A RALY IGF2BP3 SUGP2 NSA2 YLPM1 SUPT16H OASL PDS5A HECTD1 | 1.41e-07 | 718 | 141 | 20 | int:DDX21 |
| Interaction | SIRT7 interactions | NPM1 SRSF4 MYCBP2 CENPF NSD2 URB2 HUWE1 RBM28 IGF2BP3 DST SUGP2 NSA2 SYNE2 YLPM1 OASL GIGYF2 PDS5A HECTD1 NIPBL EPB41L2 | 2.48e-07 | 744 | 141 | 20 | int:SIRT7 |
| Interaction | ZC3H7A interactions | UBAP2 CNOT10 RC3H1 IGF2BP3 HOOK3 ATXN2 CPEB4 GIGYF2 SEC63 HECTD1 CNOT2 | 3.45e-07 | 215 | 141 | 11 | int:ZC3H7A |
| Interaction | STX7 interactions | NPM1 SDK2 MIA3 UBAP2 OXR1 BMP2K APBB2 FAM171B RRBP1 TMEM87A AKAP12 DST ZFYVE9 SYNE2 WDR41 SEPTIN7 SEC63 EPB41L2 | 8.32e-07 | 659 | 141 | 18 | int:STX7 |
| Interaction | PRC1 interactions | NPM1 BDP1 CENPF CTDSPL2 BAZ2B RALYL APC TACC2 URB2 RBM28 RGS12 ITIH4 KIF20A RALY IGF2BP3 NSA2 SUPT16H COBL PDS5A PATJ HECTD1 EPB41L2 | 1.11e-06 | 973 | 141 | 22 | int:PRC1 |
| Interaction | FMR1 interactions | NPM1 MIA3 ARHGAP24 UBAP2 MYCBP2 RC3H1 APC TACC2 KIF20A IGF2BP3 ATXN2 CPEB4 SUPT16H GIGYF2 HECTD1 NIPBL | 1.13e-06 | 536 | 141 | 16 | int:FMR1 |
| Interaction | POLR1G interactions | NPM1 BAZ2B ATAD5 NSD2 RC3H1 URB2 HUWE1 RBM28 KIF20A MTIF2 SUPT16H PDS5A HECTD1 NIPBL ZNF292 | 1.79e-06 | 489 | 141 | 15 | int:POLR1G |
| Interaction | FXR2 interactions | NPM1 MIA3 ARHGAP24 HIVEP1 UBAP2 BAZ2B CNOT10 RC3H1 RALYL KIF20A ATXN2 CPEB4 HECTD1 CNOT2 | 2.02e-06 | 430 | 141 | 14 | int:FXR2 |
| Interaction | H3C3 interactions | HIVEP1 SETX CTDSPL2 BAZ2B ATAD5 NSD2 MYSM1 KIF20A MTA1 NKX2-1 SUPT16H PDS5A QSER1 NIPBL ZNF292 | 2.08e-06 | 495 | 141 | 15 | int:H3C3 |
| Interaction | FXR1 interactions | SHANK1 NPM1 MIA3 HIVEP1 UBAP2 MYCBP2 CENPF RC3H1 RALYL TACC2 KIF20A ATXN2 CPEB4 GIGYF2 ALAS1 HECTD1 ERVFRD-1 | 5.51e-06 | 679 | 141 | 17 | int:FXR1 |
| Interaction | G3BP1 interactions | NPM1 ARHGAP24 ZEB1 UBAP2 SRSF4 MYCBP2 CENPF CNOT10 RC3H1 KIF20A IGF2BP3 DST SUGP2 ATXN2 CPEB4 GIGYF2 SEC63 HECTD1 CNOT2 | 5.90e-06 | 835 | 141 | 19 | int:G3BP1 |
| Interaction | ANKRD20A4P interactions | 6.60e-06 | 6 | 141 | 3 | int:ANKRD20A4P | |
| Interaction | XRCC6 interactions | NPM1 NUP50 NCOA6 ARHGAP24 ZEB1 NSD2 RC3H1 HUWE1 KIF20A RALY IGF2BP3 MTA1 SUGP2 NKX2-1 YLPM1 SUPT16H ZFHX3 DENND5A SEPTIN7 HECTD1 | 7.35e-06 | 928 | 141 | 20 | int:XRCC6 |
| Interaction | DYRK1A interactions | NPM1 BDP1 SRSF4 MYCBP2 CENPF CNOT10 HUWE1 LRP1B ITGB4 KIF20A IGF2BP3 MTA1 USP32 CCDC15 CNOT2 | 7.76e-06 | 552 | 141 | 15 | int:DYRK1A |
| Interaction | CPEB1 interactions | 8.80e-06 | 146 | 141 | 8 | int:CPEB1 | |
| Interaction | MECP2 interactions | NPM1 NUP50 SETX SRSF4 MYCBP2 NSD2 APC URB2 RBM28 RALY IGF2BP3 DST SUGP2 ZNF532 NKX2-1 CPEB4 YLPM1 SUPT16H PDS5A NKTR SEC63 NIPBL EPB41L2 ZNF292 | 9.61e-06 | 1287 | 141 | 24 | int:MECP2 |
| Interaction | CCDC86 interactions | 1.13e-05 | 151 | 141 | 8 | int:CCDC86 | |
| Interaction | ANKRD20A2P interactions | 1.15e-05 | 7 | 141 | 3 | int:ANKRD20A2P | |
| Interaction | MKI67 interactions | NPM1 NCOA6 SRSF4 CENPF NSD2 CNOT10 HAUS5 RRBP1 KIF20A DST NSA2 YLPM1 PDS5A QSER1 HECTD1 NIPBL | 1.26e-05 | 648 | 141 | 16 | int:MKI67 |
| Interaction | YTHDF2 interactions | UBAP2 BMP2K CNOT10 RC3H1 HUWE1 ATXN2 CPEB4 SEPTIN7 AKAP1 HECTD1 CNOT2 | 1.27e-05 | 312 | 141 | 11 | int:YTHDF2 |
| Interaction | RBM47 interactions | 1.38e-05 | 204 | 141 | 9 | int:RBM47 | |
| Interaction | SORT1 interactions | 1.61e-05 | 208 | 141 | 9 | int:SORT1 | |
| Interaction | RPA4 interactions | NPM1 NUP50 UBAP2 APC IGF2BP3 DST SUGP2 STARD9 SUPT16H SEC63 AKAP1 CNOT2 EPB41L2 | 1.79e-05 | 452 | 141 | 13 | int:RPA4 |
| Interaction | BRCA1 interactions | NPM1 EME1 SDK2 HIVEP1 SETX UBAP2 CENPF NSD2 HUWE1 RBM28 AKAP12 KIF20A RALY FANCB IGF2BP3 DST SLF2 SUPT16H PDS5A C2CD6 SEPTIN7 NIPBL ZHX1 | 1.85e-05 | 1249 | 141 | 23 | int:BRCA1 |
| Interaction | DDX1 interactions | NPM1 ARHGAP24 ZEB1 RC3H1 HUWE1 KIF20A RALY CRACD IGF2BP3 ATXN2 CPEB4 GIGYF2 HECTD1 | 2.30e-05 | 463 | 141 | 13 | int:DDX1 |
| Interaction | ZC3HAV1 interactions | NPM1 UBAP2 SRSF4 NSD2 CNOT10 RC3H1 RBM28 KIF20A IGF2BP3 ATXN2 NSA2 CPEB4 OASL AKAP1 HECTD1 | 2.32e-05 | 606 | 141 | 15 | int:ZC3HAV1 |
| Interaction | YWHAH interactions | NCOA6 UAP1 HIVEP1 SETX UBAP2 MYCBP2 TBC1D5 APC HUWE1 RGS12 DST SLF2 STARD9 SYNE2 COBL GIGYF2 NKTR PATJ AKAP1 HECTD1 EPB41L2 | 2.71e-05 | 1102 | 141 | 21 | int:YWHAH |
| Interaction | PURG interactions | 2.80e-05 | 223 | 141 | 9 | int:PURG | |
| Interaction | TNRC6A interactions | NCOA6 CNOT10 RC3H1 ITGB4 KIF20A CPEB4 GIGYF2 SEC63 AKAP1 CNOT2 | 2.85e-05 | 280 | 141 | 10 | int:TNRC6A |
| Interaction | RSL1D1 interactions | NPM1 SRSF4 NSD2 RC3H1 RBM28 KIF20A RALY DST NSA2 YLPM1 SUPT16H NKTR HECTD1 | 3.27e-05 | 479 | 141 | 13 | int:RSL1D1 |
| Interaction | TERF2IP interactions | NUP50 NCOA6 ZEB1 HIVEP1 SETX ATAD5 NSD2 MYSM1 SUGP2 PDS5A QSER1 HECTD1 NIPBL ZNF292 | 3.39e-05 | 552 | 141 | 14 | int:TERF2IP |
| Interaction | SIRT6 interactions | NPM1 MIA3 UBAP2 MYCBP2 APC HUWE1 RBM28 RRBP1 KIF20A YLPM1 SUPT16H PDS5A NKTR ZNF83 HECTD1 | 3.50e-05 | 628 | 141 | 15 | int:SIRT6 |
| Interaction | RPL14 interactions | NPM1 ARHGAP24 ZEB1 NSD2 RC3H1 URB2 RBM28 REV3L KIF20A IGF2BP3 NSA2 STARD9 OASL HECTD1 | 3.52e-05 | 554 | 141 | 14 | int:RPL14 |
| Interaction | PATL1 interactions | 3.55e-05 | 177 | 141 | 8 | int:PATL1 | |
| Interaction | SMARCA5 interactions | NPM1 ARHGAP24 NSD2 HUWE1 KIF20A RALY MTA1 NKX2-1 SUPT16H SEPTIN7 HECTD1 EPB41L2 | 3.62e-05 | 415 | 141 | 12 | int:SMARCA5 |
| Interaction | ANKRD18A interactions | 3.88e-05 | 10 | 141 | 3 | int:ANKRD18A | |
| Interaction | SRPK2 interactions | NPM1 NUP50 SDK2 HIVEP1 SRSF4 MARCHF10 MYCBP2 RC3H1 URB2 RBM28 RALY NSA2 SUPT16H NKTR HECTD1 EPB41L2 | 4.30e-05 | 717 | 141 | 16 | int:SRPK2 |
| Interaction | PLEC interactions | TMIGD1 NUP50 BMP2K NSD2 URB2 RRBP1 ITGB4 KIF20A HOOK3 DST SYNE2 QSER1 | 5.10e-05 | 430 | 141 | 12 | int:PLEC |
| Interaction | ANKRD20A1 interactions | 5.31e-05 | 11 | 141 | 3 | int:ANKRD20A1 | |
| Interaction | H2BC8 interactions | NPM1 NUP50 EME1 ZEB1 CTDSPL2 ATAD5 NSD2 MYSM1 KIF20A SUPT16H PDS5A QSER1 NIPBL ZNF292 | 5.37e-05 | 576 | 141 | 14 | int:H2BC8 |
| Interaction | ILF3 interactions | NPM1 ARHGAP24 ZEB1 CTDSPL2 NSD2 CNOT10 RC3H1 URB2 HUWE1 RBM28 RRBP1 KIF20A RALY IGF2BP3 ATXN2 NSA2 YLPM1 SUPT16H | 5.49e-05 | 896 | 141 | 18 | int:ILF3 |
| Interaction | HECTD1 interactions | NPM1 MYCBP2 CENPF ATAD5 NSD2 APC TACC2 URB2 HUWE1 RBM28 RRBP1 RALY IGF2BP3 SUGP2 NSA2 IGHMBP2 SUPT16H AKAP1 HECTD1 | 5.71e-05 | 984 | 141 | 19 | int:HECTD1 |
| Interaction | FAM120C interactions | 6.08e-05 | 191 | 141 | 8 | int:FAM120C | |
| Interaction | PABPC4 interactions | NPM1 RC3H1 RRBP1 KIF20A IGF2BP3 ATXN2 NSA2 CPEB4 YLPM1 OASL AKAP1 HECTD1 | 6.63e-05 | 442 | 141 | 12 | int:PABPC4 |
| Interaction | CENPA interactions | NPM1 HIVEP1 ATAD5 NSD2 MYSM1 MTA1 SLF2 SUPT16H PDS5A NIPBL ZNF292 | 7.12e-05 | 377 | 141 | 11 | int:CENPA |
| Interaction | RAB9A interactions | MIA3 OXR1 TBC1D5 APBB2 RBM28 RRBP1 TMEM87A DST ZFYVE9 SYNE2 USP32 WDR41 SEC63 AKAP1 | 7.59e-05 | 595 | 141 | 14 | int:RAB9A |
| Interaction | GLDC interactions | ARHGAP24 SRSF4 RC3H1 RRBP1 IGF2BP3 SUGP2 ATXN2 COBL GIGYF2 PATJ | 8.95e-05 | 321 | 141 | 10 | int:GLDC |
| Interaction | LSM14A interactions | 9.17e-05 | 260 | 141 | 9 | int:LSM14A | |
| Interaction | SSRP1 interactions | NPM1 ARHGAP24 SETX HUWE1 KIF20A RALY IGF2BP3 MTA1 SUGP2 INTS2 NKX2-1 YLPM1 SUPT16H HECTD1 NIPBL | 9.32e-05 | 685 | 141 | 15 | int:SSRP1 |
| Interaction | NPM1 interactions | NPM1 BDP1 NUP50 ZEB1 HIVEP1 CENPF NSD2 CNOT10 RC3H1 HUWE1 RBM28 RRBP1 AKAP12 KIF20A IGF2BP3 NSA2 SYNE2 SUPT16H OASL ANKRD18A HECTD1 | 9.35e-05 | 1201 | 141 | 21 | int:NPM1 |
| Interaction | REXO4 interactions | 9.45e-05 | 261 | 141 | 9 | int:REXO4 | |
| Interaction | RBMS1 interactions | 1.07e-04 | 207 | 141 | 8 | int:RBMS1 | |
| Interaction | CGAS interactions | MYCBP2 APBB2 RBM28 RRBP1 KIF20A RALY NKX2-1 NSA2 IGHMBP2 OASL | 1.10e-04 | 329 | 141 | 10 | int:CGAS |
| Interaction | H2BC21 interactions | NPM1 NUP50 EME1 ARHGAP24 CENPF CTDSPL2 ATAD5 NSD2 HUWE1 KIF20A MTA1 SUPT16H QSER1 NIPBL ZNF292 | 1.11e-04 | 696 | 141 | 15 | int:H2BC21 |
| Interaction | TOP1 interactions | NPM1 NCOA6 ARHGAP24 NSD2 RC3H1 RBM28 KIF20A RALY MTA1 INTS2 NKX2-1 YLPM1 SUPT16H HECTD1 NIPBL | 1.11e-04 | 696 | 141 | 15 | int:TOP1 |
| Interaction | HNRNPU interactions | NPM1 NUP50 EME1 ARHGAP24 ZEB1 NSD2 RC3H1 HUWE1 RBM28 ITGB4 KIF20A RALY IGF2BP3 ATXN2 IGHMBP2 SUPT16H OASL SEPTIN7 HECTD1 | 1.11e-04 | 1035 | 141 | 19 | int:HNRNPU |
| Interaction | CPEB4 interactions | 1.16e-04 | 156 | 141 | 7 | int:CPEB4 | |
| Interaction | CNTNAP2 interactions | 1.25e-04 | 158 | 141 | 7 | int:CNTNAP2 | |
| Interaction | NUP155 interactions | NUP50 MIA3 TACC2 HUWE1 TMEM87A KIF20A ZFYVE9 NKX2-1 SYNE2 WDR41 AKAP1 HECTD1 | 1.36e-04 | 477 | 141 | 12 | int:NUP155 |
| Interaction | HNRNPCL2 interactions | 1.36e-04 | 274 | 141 | 9 | int:HNRNPCL2 | |
| Interaction | CNOT11 interactions | 1.37e-04 | 112 | 141 | 6 | int:CNOT11 | |
| Interaction | SYNCRIP interactions | ARHGAP24 ZEB1 RC3H1 APBB2 RBM28 KIF20A RALY IGF2BP3 MTA1 ATXN2 CPEB4 USP32 OASL HECTD1 EPB41L2 | 1.63e-04 | 721 | 141 | 15 | int:SYNCRIP |
| Interaction | NAA40 interactions | NPM1 NUP50 UBAP2 ATAD5 TBC1D5 TACC2 RRBP1 AKAP12 CRACD IGF2BP3 DST SUGP2 YLPM1 SUPT16H GIGYF2 AKAP1 NIPBL EPB41L2 | 1.66e-04 | 978 | 141 | 18 | int:NAA40 |
| Interaction | FLNA interactions | NPM1 UAP1 ARHGAP24 BMP2K NSD2 APC AKAP12 KIF20A CRACD COBL PDS5A SEPTIN7 PATJ NIPBL | 1.85e-04 | 648 | 141 | 14 | int:FLNA |
| Interaction | RCOR1 interactions | NPM1 HIVEP1 MYCBP2 CENPF APC HUWE1 MTA1 DST NKX2-1 GIGYF2 ZFHX3 AKAP1 | 1.88e-04 | 494 | 141 | 12 | int:RCOR1 |
| Interaction | KPNA4 interactions | 1.89e-04 | 225 | 141 | 8 | int:KPNA4 | |
| Interaction | ANKRD17 interactions | 1.95e-04 | 226 | 141 | 8 | int:ANKRD17 | |
| Interaction | RAB35 interactions | APBB2 APC TMEM87A AKAP12 DST ZFYVE9 SYNE2 USP32 WDR41 SEPTIN7 SEC63 AKAP1 EPB41L2 | 1.98e-04 | 573 | 141 | 13 | int:RAB35 |
| Interaction | MYCBP2 interactions | 2.03e-04 | 355 | 141 | 10 | int:MYCBP2 | |
| Interaction | NLE1 interactions | 2.07e-04 | 228 | 141 | 8 | int:NLE1 | |
| Interaction | DDX17 interactions | ARHGAP24 ZEB1 RC3H1 RBM28 KIF20A RALY IGF2BP3 ATXN2 YLPM1 HECTD1 NIPBL | 2.08e-04 | 426 | 141 | 11 | int:DDX17 |
| Interaction | H1-4 interactions | NPM1 NUP50 ARHGAP24 NSD2 RC3H1 TACC2 RBM28 REV3L KIF20A IGF2BP3 NSA2 OASL GIGYF2 HECTD1 | 2.10e-04 | 656 | 141 | 14 | int:H1-4 |
| Interaction | PPP1CC interactions | NPM1 NUP50 SRSF4 BMP2K MYCBP2 APC TACC2 RBM28 KIF20A IGF2BP3 ZFYVE9 STARD9 YLPM1 SUPT16H EPB41L2 | 2.10e-04 | 738 | 141 | 15 | int:PPP1CC |
| Interaction | IGF2BP2 interactions | NPM1 RC3H1 KIF20A RALY IGF2BP3 ATXN2 CPEB4 OASL AKAP1 HECTD1 | 2.13e-04 | 357 | 141 | 10 | int:IGF2BP2 |
| Interaction | RNF123 interactions | SETX CENPF BAZ2B GPAM ANKRD20A3P HUWE1 RBM28 REV3L FREM2 IGF2BP3 AFAP1L2 DST PDS5A ANKRD18A LRRC7 EPB41L2 | 2.15e-04 | 824 | 141 | 16 | int:RNF123 |
| Interaction | DDX6 interactions | CNOT10 RC3H1 HUWE1 RRBP1 IGF2BP3 ATXN2 CPEB4 OASL GIGYF2 AKAP1 HECTD1 CNOT2 | 2.22e-04 | 503 | 141 | 12 | int:DDX6 |
| Interaction | CNOT9 interactions | 2.26e-04 | 231 | 141 | 8 | int:CNOT9 | |
| Interaction | MTDH interactions | DMTF1 NPM1 ABCA12 RC3H1 RBM28 RRBP1 RALY SUPT16H DNAI4 SEC63 HECTD1 SDK1 | 2.30e-04 | 505 | 141 | 12 | int:MTDH |
| Interaction | C2CD4B interactions | 2.51e-04 | 44 | 141 | 4 | int:C2CD4B | |
| Interaction | RFC3 interactions | 2.52e-04 | 177 | 141 | 7 | int:RFC3 | |
| Interaction | PAX6 interactions | 2.59e-04 | 366 | 141 | 10 | int:PAX6 | |
| Interaction | HDAC1 interactions | NPM1 NUP50 ZEB1 HIVEP1 MYCBP2 CENPF NSD2 APC GPAM KIF20A MTA1 DST NKX2-1 SYNE2 GIGYF2 ZFHX3 AKAP1 HECTD1 ZHX1 | 2.66e-04 | 1108 | 141 | 19 | int:HDAC1 |
| Interaction | EIF4ENIF1 interactions | 2.68e-04 | 300 | 141 | 9 | int:EIF4ENIF1 | |
| Interaction | LRPAP1 interactions | 2.79e-04 | 180 | 141 | 7 | int:LRPAP1 | |
| Interaction | G3BP2 interactions | NPM1 ZEB1 UBAP2 MYCBP2 CNOT10 RC3H1 RRBP1 KIF20A IGF2BP3 ATXN2 CPEB4 HECTD1 | 2.90e-04 | 518 | 141 | 12 | int:G3BP2 |
| Interaction | TOMM20 interactions | 2.93e-04 | 240 | 141 | 8 | int:TOMM20 | |
| Interaction | R3HDM2 interactions | 2.96e-04 | 129 | 141 | 6 | int:R3HDM2 | |
| Interaction | RPL4 interactions | NPM1 ARHGAP24 ZEB1 NSD2 RC3H1 URB2 HUWE1 RBM28 KIF20A IGF2BP3 ATXN2 NSA2 OASL SEC63 HECTD1 | 3.04e-04 | 764 | 141 | 15 | int:RPL4 |
| Interaction | ZNF330 interactions | NPM1 ATAD5 NSD2 URB2 RBM28 MYSM1 KIF20A SUPT16H PDS5A NIPBL ZNF292 | 3.08e-04 | 446 | 141 | 11 | int:ZNF330 |
| Interaction | KDM1A interactions | ZEB1 HIVEP1 MYCBP2 CENPF NSD2 APC HUWE1 MTA1 DST INTS2 ZNF532 NKX2-1 SUPT16H GIGYF2 PDS5A ZFHX3 AKAP1 | 3.16e-04 | 941 | 141 | 17 | int:KDM1A |
| Interaction | SYNGAP1 interactions | 3.17e-04 | 307 | 141 | 9 | int:SYNGAP1 | |
| Interaction | B3GAT1 interactions | 3.28e-04 | 377 | 141 | 10 | int:B3GAT1 | |
| Interaction | RPL5 interactions | NPM1 RC3H1 HUWE1 RBM28 RRBP1 KIF20A IGF2BP3 ATXN2 NSA2 IGHMBP2 SUPT16H HECTD1 EPB41L2 | 3.39e-04 | 606 | 141 | 13 | int:RPL5 |
| Interaction | KRR1 interactions | 3.42e-04 | 379 | 141 | 10 | int:KRR1 | |
| Interaction | CDV3 interactions | 3.45e-04 | 86 | 141 | 5 | int:CDV3 | |
| Cytoband | 5q13.3 | 1.84e-04 | 35 | 144 | 3 | 5q13.3 | |
| GeneFamily | Ankyrin repeat domain containing | SHANK1 ANKRD31 ANKRD20A2P ANKRD20A3P ANKRD36B ANKRD20A4P ANKRD18A HECTD1 ANKRD20A1 | 5.60e-06 | 242 | 96 | 9 | 403 |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 6.30e-05 | 15 | 96 | 3 | 529 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.79e-04 | 53 | 96 | 4 | 532 | |
| GeneFamily | RNA binding motif containing | 9.57e-04 | 213 | 96 | 6 | 725 | |
| GeneFamily | PDZ domain containing | 1.30e-03 | 152 | 96 | 5 | 1220 | |
| GeneFamily | UPF1 like RNA helicases | 1.49e-03 | 11 | 96 | 2 | 1169 | |
| GeneFamily | CCR4-NOT transcription complex | 1.49e-03 | 11 | 96 | 2 | 1023 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.79e-03 | 181 | 96 | 5 | 694 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZEB1 HIVEP1 SETX BMP2K MYCBP2 CENPF BAZ2B APBB2 APC REV3L TMEM87A IGF2BP3 DST ZFYVE9 ATXN2 MTIF2 SYNE2 GIGYF2 PDS5A ZFHX3 DENND5A NIPBL CNOT2 ZNF292 | 3.26e-11 | 856 | 141 | 24 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | HIVEP1 MYCBP2 CENPF BAZ2B REV3L IGF2BP3 DST ZFYVE9 ATXN2 GIGYF2 PDS5A DENND5A CNOT2 ZNF292 | 2.40e-07 | 466 | 141 | 14 | M13522 |
| Coexpression | GABRIELY_MIR21_TARGETS | MYCBP2 APC GPAM REV3L PER3 ZNF532 SYNE2 SEC63 HECTD1 NIPBL ZNF292 | 5.01e-07 | 289 | 141 | 11 | M2196 |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1 | ARHGAP24 UBAP2 CENPF ABCA12 TBC1D5 APBB2 HUWE1 KIF20A FREM2 DST SUPT16H PPP1R1C QSER1 DENND5A | 1.22e-06 | 534 | 141 | 14 | M12522 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | BDP1 MIA3 ARHGAP24 FRMPD4 MYCBP2 HS6ST2 RALYL APC MDGA2 REV3L FAM171B LRP1B ANKRD36B SUGP2 CPEB4 ZFHX3 ANKRD18A LRRC7 C2CD6 ARMH4 | 2.04e-06 | 1106 | 141 | 20 | M39071 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | NPM1 BDP1 SETX MYCBP2 BAZ2B APC REV3L SYNE2 NKTR QSER1 ZNF83 SEC63 HECTD1 NIPBL ZHX1 | 2.69e-06 | 656 | 141 | 15 | M18979 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | GABRB1 BDP1 FRMPD4 MYCBP2 RALYL MDGA2 REV3L FAM171B LRP1B ANKRD36B CPEB4 ZFHX3 LRRC7 AKAP1 ZNF292 | 6.20e-06 | 703 | 141 | 15 | M39070 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 9.35e-06 | 90 | 141 | 6 | M39250 | |
| Coexpression | GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_DN | 1.24e-05 | 198 | 141 | 8 | M6033 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | OXR1 BMP2K PSG5 FAM171B ANKRD36B IGF2BP3 CPEB4 NKTR QSER1 SEC63 ANKRD20A1 | 1.25e-05 | 404 | 141 | 11 | M19488 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL | NUP50 ZEB1 UBAP2 CENPF CTDSPL2 ATAD5 NSD2 CNOT10 HAUS5 NAA50 KIF20A ANKRD36B IGF2BP3 SYNE2 CCDC15 ZNF83 EPB41L2 | 1.26e-05 | 939 | 141 | 17 | M45768 |
| Coexpression | GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN | 1.28e-05 | 199 | 141 | 8 | M3177 | |
| Coexpression | GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 1.33e-05 | 200 | 141 | 8 | M7432 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP | 1.33e-05 | 200 | 141 | 8 | M6262 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 1.33e-05 | 200 | 141 | 8 | M9136 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 1.76e-05 | 208 | 141 | 8 | M39233 | |
| Coexpression | KIM_WT1_TARGETS_DN | CENPF BAZ2B REV3L KIF20A IGF2BP3 PER3 SUGP2 SLF2 NKTR AKAP1 ZNF292 | 5.08e-05 | 471 | 141 | 11 | M17859 |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 7.74e-05 | 81 | 141 | 5 | M39253 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_UP | 9.21e-05 | 84 | 141 | 5 | M15130 | |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_UP | 1.03e-04 | 86 | 141 | 5 | MM825 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP | 1.05e-04 | 199 | 141 | 7 | M4521 | |
| Coexpression | GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN | 1.05e-04 | 199 | 141 | 7 | M316 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | 1.05e-04 | 199 | 141 | 7 | M6264 | |
| Coexpression | GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN | 1.08e-04 | 200 | 141 | 7 | M9486 | |
| Coexpression | GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_DN | 1.08e-04 | 200 | 141 | 7 | M7164 | |
| Coexpression | GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP | 1.08e-04 | 200 | 141 | 7 | M6480 | |
| Coexpression | MILI_PSEUDOPODIA | 1.30e-04 | 48 | 141 | 4 | M17507 | |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP | 1.37e-04 | 145 | 141 | 6 | M3045 | |
| Coexpression | MILI_PSEUDOPODIA | 1.65e-04 | 51 | 141 | 4 | MM824 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN | MIA3 ARHGAP24 TACC2 RRBP1 AKAP12 AFAP1L2 HOOK3 SYNE2 ZFHX3 NKTR AKAP1 | 1.75e-04 | 542 | 141 | 11 | M19529 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | CACNA1D MIA3 MYCBP2 APC HUWE1 CRACD DST PER3 ATXN2 SYNE2 CPEB4 GIGYF2 SEC63 HECTD1 ZNF292 | 1.83e-04 | 946 | 141 | 15 | M39169 |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 1.97e-04 | 155 | 141 | 6 | M39246 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 2.28e-04 | 300 | 141 | 8 | M8702 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | BDP1 EME1 ZEB1 HIVEP1 MYCBP2 CTDSPL2 ATAD5 TBC1D5 RC3H1 APC ZFYVE9 SLF2 NSA2 MTIF2 YLPM1 MRNIP ZFHX3 QSER1 SEPTIN7 HECTD1 ZHX1 CNOT2 ZNF292 | 2.28e-12 | 564 | 139 | 23 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | NPM1 BDP1 NCOA6 EME1 CENPF ATAD5 TBC1D5 REV3L MTIF2 SYNE2 SUPT16H CCDC15 PDS5A HECTD1 NIPBL ZNF292 | 2.28e-10 | 311 | 139 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | NPM1 BDP1 EME1 SETX CENPF ATAD5 TBC1D5 APC KIF20A DST ZFYVE9 SUPT16H GIGYF2 PDS5A ALAS1 HECTD1 NIPBL CNOT2 ZNF292 | 2.48e-10 | 469 | 139 | 19 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | NPM1 BDP1 ZEB1 CENPF ATAD5 TBC1D5 APC MDGA2 ZFYVE9 SLF2 NSA2 MTIF2 SYNE2 YLPM1 CCDC15 QSER1 HECTD1 NIPBL CNOT2 ZNF292 | 5.30e-09 | 629 | 139 | 20 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | NPM1 BDP1 NUP50 NCOA6 EME1 ZEB1 SETX CENPF CTDSPL2 ATAD5 NSD2 APC REV3L FAM171B CRACD IGF2BP3 HOOK3 MTIF2 SYNE2 SUPT16H PDS5A ZFHX3 QSER1 SEPTIN7 SEC63 NIPBL ZNF292 | 3.94e-08 | 1257 | 139 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | DMTF1 ZEB1 SRSF4 CTDSPL2 TBC1D5 APC CRACD ZFYVE9 NSA2 MTIF2 SYNE2 YLPM1 USP32 CCDC15 HECTD1 SDK1 CNOT2 ZNF292 | 7.00e-08 | 595 | 139 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NPM1 BDP1 NCOA6 EME1 CENPF ATAD5 TBC1D5 MDGA2 REV3L CRACD FREM2 IGF2BP3 NKX2-1 MTIF2 SYNE2 SUPT16H CCDC15 DNAI4 PDS5A HECTD1 NIPBL ZNF292 | 4.76e-07 | 989 | 139 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NPM1 BDP1 NUP50 NCOA6 EME1 ZEB1 SETX CENPF CTDSPL2 ATAD5 NSD2 APC REV3L FAM171B CRACD IGF2BP3 HOOK3 MTIF2 SYNE2 SUPT16H PDS5A ZFHX3 QSER1 SEPTIN7 SEC63 NIPBL ZNF292 | 7.74e-07 | 1459 | 139 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | BDP1 NCOA6 EME1 CENPF ATAD5 TBC1D5 MDGA2 HUWE1 CRACD MTIF2 SYNE2 SUPT16H CCDC15 DNAI4 PDS5A NKTR HECTD1 NIPBL ZNF292 | 2.10e-06 | 831 | 139 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 4.99e-06 | 192 | 139 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | NPM1 EME1 ZEB1 SETX CENPF CTDSPL2 ATAD5 NSD2 APC MDGA2 FAM171B CRACD MTIF2 SYNE2 SUPT16H CCDC15 DNAI4 QSER1 NIPBL ZNF292 | 1.92e-05 | 1060 | 139 | 20 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 6.08e-05 | 204 | 139 | 8 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | NPM1 NCOA6 EME1 ZEB1 SETX CENPF CTDSPL2 ATAD5 APC REV3L CRACD NSA2 SYNE2 YLPM1 SUPT16H OASL ZFHX3 QSER1 SEPTIN7 NIPBL ZNF292 | 6.53e-05 | 1252 | 139 | 21 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | NPM1 BDP1 CTDSPL2 ATAD5 APC REV3L SLF2 YLPM1 QSER1 NIPBL ZNF292 | 1.32e-04 | 432 | 139 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.56e-04 | 298 | 139 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.60e-04 | 123 | 139 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | BDP1 MYCBP2 CTDSPL2 APC HUWE1 REV3L HOOK3 PER3 GIGYF2 ZNF292 | 1.85e-04 | 375 | 139 | 10 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 2.28e-04 | 186 | 139 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | NPM1 BDP1 MARCHF10 CENPF CTDSPL2 ATAD5 APC REV3L SLF2 NKX2-1 MTIF2 SYNE2 YLPM1 ZFHX3 QSER1 NIPBL ZNF292 | 2.59e-04 | 989 | 139 | 17 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 2.77e-04 | 192 | 139 | 7 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.99e-04 | 138 | 139 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | GABRB1 SETX GBP7 CTDSPL2 ATAD5 HS6ST2 RDH10 HUWE1 NAA50 AKAP12 HOOK3 YLPM1 COBL ZNF292 ARMH4 | 3.43e-04 | 826 | 139 | 15 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | GABRB1 OXR1 CTDSPL2 HS6ST2 RDH10 HUWE1 FREM2 IGF2BP3 HOOK3 DST YLPM1 SUPT16H GIGYF2 ZFHX3 ZNF292 | 3.89e-04 | 836 | 139 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | OXR1 CTDSPL2 HS6ST2 HUWE1 IGF2BP3 HOOK3 YLPM1 SUPT16H GIGYF2 ZFHX3 ZNF292 | 4.02e-04 | 492 | 139 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | BDP1 EME1 CENPF ATAD5 FREM2 NKX2-1 MTIF2 SYNE2 SUPT16H PDS5A NIPBL | 4.45e-04 | 498 | 139 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.66e-04 | 275 | 139 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500 | 4.72e-04 | 422 | 139 | 10 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | NPM1 EME1 ZEB1 SETX CENPF CTDSPL2 ATAD5 HS6ST2 APC HOOK3 SLF2 SUPT16H OASL ZFHX3 QSER1 SEPTIN7 SEC63 NIPBL ZNF292 | 4.74e-04 | 1241 | 139 | 19 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst-Confounder_removed-fold2.0_adjp0.05 | SDK2 OXR1 BAZ2B TBC1D5 HAUS5 RALYL RDH10 RBM28 FAM171B LRP1B RGS12 AKAP12 FAN1 PER3 ZNF532 LOXL3 ZHX1 SDK1 ZNF292 | 4.93e-04 | 1245 | 139 | 19 | PCBC_ratio_MESO-30 amniotic fluid MSC_vs_MESO-30 blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.98e-04 | 349 | 139 | 9 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_k1_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.01e-04 | 152 | 139 | 6 | gudmap_developingKidney_e15.5_Proximal Tubules_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#1_top-relative-expression-ranked_500 | 5.35e-04 | 101 | 139 | 5 | gudmap_developingGonad_e14.5_ ovary_500_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | GABRB1 CTDSPL2 HS6ST2 HUWE1 HOOK3 DST YLPM1 GIGYF2 ZFHX3 ZNF292 | 5.37e-04 | 429 | 139 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.77e-04 | 284 | 139 | 8 | gudmap_developingGonad_e16.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 6.96e-04 | 107 | 139 | 5 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_500 | 7.23e-04 | 163 | 139 | 6 | gudmap_developingKidney_e15.5_cortic collect duct_500_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.13e-04 | 230 | 139 | 7 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.30e-09 | 184 | 144 | 9 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | AT2_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | ABCA12 HS6ST2 ANKRD20A2P ANKRD20A3P ITGB4 PER3 ANKRD20A4P TMEM132D | 1.12e-08 | 131 | 144 | 8 | ff4e618bd944f852bbd34438f740187aca82460f |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-07 | 187 | 144 | 8 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-07 | 189 | 144 | 8 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.18e-07 | 192 | 144 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-07 | 193 | 144 | 8 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.27e-07 | 193 | 144 | 8 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.97e-07 | 200 | 144 | 8 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.97e-07 | 200 | 144 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.44e-07 | 155 | 144 | 7 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-06 | 184 | 144 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 2.34e-06 | 184 | 144 | 7 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-06 | 184 | 144 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-06 | 184 | 144 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-06 | 187 | 144 | 7 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-06 | 191 | 144 | 7 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-06 | 191 | 144 | 7 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-06 | 191 | 144 | 7 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-06 | 193 | 144 | 7 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 3.21e-06 | 193 | 144 | 7 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-06 | 193 | 144 | 7 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-06 | 194 | 144 | 7 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-06 | 194 | 144 | 7 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.32e-06 | 194 | 144 | 7 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 3.43e-06 | 195 | 144 | 7 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 195 | 144 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-06 | 195 | 144 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.67e-06 | 197 | 144 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 3.67e-06 | 197 | 144 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.92e-06 | 199 | 144 | 7 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.92e-06 | 199 | 144 | 7 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 3.92e-06 | 199 | 144 | 7 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.06e-06 | 200 | 144 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.06e-06 | 200 | 144 | 7 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.06e-06 | 200 | 144 | 7 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.06e-06 | 200 | 144 | 7 | e3051dcf9b5c8e4dc71a8080b7a7aafea46f2b2b | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 4.06e-06 | 200 | 144 | 7 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.06e-06 | 200 | 144 | 7 | 1ce9599cc9d8158e8842ca56f35fa7809c234849 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.06e-06 | 200 | 144 | 7 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO---L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.06e-06 | 200 | 144 | 7 | 7b845aabfbdfe893acc9334a5707833761bed60b | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.06e-06 | 200 | 144 | 7 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 4.06e-06 | 200 | 144 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.06e-06 | 200 | 144 | 7 | 0638273fc0910f47fe7a0b6d9a8639b0e9976d13 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.06e-06 | 200 | 144 | 7 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.06e-06 | 200 | 144 | 7 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.17e-06 | 130 | 144 | 6 | 1ff28e9d3dc9a791e07d815f8fbb48f75d3f275b | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-06 | 145 | 144 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.32e-05 | 159 | 144 | 6 | e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.47e-05 | 162 | 144 | 6 | 80317c4253bf8e897782e562f29835f181c65b98 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.74e-05 | 167 | 144 | 6 | 78d264af390bd89942ffbb2991dc94f50756d4c9 | |
| ToppCell | 3'_v3-blood-Mast|blood / Manually curated celltypes from each tissue | 2.06e-05 | 172 | 144 | 6 | e7a46bbeff749ca59b9f1357409ce1ad59dd22dd | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 2.20e-05 | 174 | 144 | 6 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-05 | 174 | 144 | 6 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-05 | 175 | 144 | 6 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-05 | 178 | 144 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.58e-05 | 179 | 144 | 6 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-05 | 180 | 144 | 6 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 2.75e-05 | 181 | 144 | 6 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-05 | 182 | 144 | 6 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 2.92e-05 | 183 | 144 | 6 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.92e-05 | 183 | 144 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 3.01e-05 | 184 | 144 | 6 | c6affa0b12510363258f65e46bf2d47bf4a8e75f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-05 | 184 | 144 | 6 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 3.10e-05 | 185 | 144 | 6 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP1_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.10e-05 | 185 | 144 | 6 | a8946379fc066903fe8f4bc9cbf693b7b424a0cd | |
| ToppCell | IPF-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 3.20e-05 | 186 | 144 | 6 | 962c2dada19185628ead77c32fcb07fa95114247 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.20e-05 | 186 | 144 | 6 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.20e-05 | 186 | 144 | 6 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | 3.20e-05 | 186 | 144 | 6 | b05c394aa3573ba855abc3066739ca193883b0c3 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.30e-05 | 187 | 144 | 6 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 187 | 144 | 6 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 187 | 144 | 6 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 3.40e-05 | 188 | 144 | 6 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.40e-05 | 188 | 144 | 6 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-05 | 188 | 144 | 6 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | IPF-Myeloid-cDC1|IPF / Disease state, Lineage and Cell class | 3.40e-05 | 188 | 144 | 6 | 2331a2bae1383820d598e93aa86c75b101069bac | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-05 | 189 | 144 | 6 | bfc76a72b600d641c8fe58346e5d8986c34f3981 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-05 | 189 | 144 | 6 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-05 | 189 | 144 | 6 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.60e-05 | 190 | 144 | 6 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.60e-05 | 190 | 144 | 6 | 59720dfe9de1b980807644536c919d2a02ba69dd | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 190 | 144 | 6 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.60e-05 | 190 | 144 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-05 | 190 | 144 | 6 | cc17ab84a9328124f146951c06be3eff9650d9fd | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 3.71e-05 | 191 | 144 | 6 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 | |
| ToppCell | COPD-Myeloid-cDC1|COPD / Disease state, Lineage and Cell class | 3.82e-05 | 192 | 144 | 6 | bd3d00b094d92463b06023361a71240851a542b8 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 3.82e-05 | 192 | 144 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-05 | 193 | 144 | 6 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 3.93e-05 | 193 | 144 | 6 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.05e-05 | 194 | 144 | 6 | 7a66bd7d4fc9c6db861cedd2487f241e406869d1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-05 | 194 | 144 | 6 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-05 | 194 | 144 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.05e-05 | 194 | 144 | 6 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.16e-05 | 195 | 144 | 6 | 32ec72103faccc9e37c0ecedff1998e7df6a19f6 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.16e-05 | 195 | 144 | 6 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.16e-05 | 195 | 144 | 6 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 4.28e-05 | 196 | 144 | 6 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.28e-05 | 196 | 144 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.28e-05 | 196 | 144 | 6 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.28e-05 | 196 | 144 | 6 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.35e-05 | 49 | 82 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.88e-07 | 180 | 141 | 10 | 4541_DN | |
| Disease | hair colour measurement | ARHGAP24 REV3L AKAP12 RALY FREM2 IGHMBP2 SYNE2 UNC13C QSER1 ZNF83 AKAP1 EPB41L2 | 2.93e-05 | 615 | 136 | 12 | EFO_0007822 |
| Disease | depressive symptom measurement | 1.67e-04 | 426 | 136 | 9 | EFO_0007006 | |
| Disease | Epidermolysis Bullosa Simplex | 2.09e-04 | 5 | 136 | 2 | C0079298 | |
| Disease | Cornelia de Lange syndrome (implicated_via_orthology) | 3.13e-04 | 6 | 136 | 2 | DOID:11725 (implicated_via_orthology) | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | GABRB1 CACNA1D HIVEP1 TBC1D5 MDGA2 TACC2 REV3L ATXN2 CPEB4 ZFHX3 LUZP2 SDK1 | 3.47e-04 | 801 | 136 | 12 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | wellbeing measurement | HIVEP1 MARCHF10 BAZ2B MTA1 ATXN2 YLPM1 OASL ZFHX3 ALAS1 TAP2 SDK1 | 3.75e-04 | 692 | 136 | 11 | EFO_0007869 |
| Disease | coronary artery disease | ANKRD31 NCOA6 MIA3 ZEB1 RRBP1 ITIH4 AKAP12 CRACD AFAP1L2 ATXN2 TMEM132D GIGYF2 LRRC7 DENND5A SEC63 | 4.16e-04 | 1194 | 136 | 15 | EFO_0001645 |
| Disease | Neurodevelopmental delay | 4.36e-04 | 7 | 136 | 2 | C4022738 | |
| Disease | Malignant neoplasm of breast | NCOA6 ZEB1 CENPF NSD2 RALYL TACC2 AKAP12 LIPE HOOK3 PER3 ZNF532 SYNE2 LRRC7 NIPBL | 4.54e-04 | 1074 | 136 | 14 | C0006142 |
| Disease | body weight | GABRB1 DMTF1 HIVEP1 ATAD5 RALYL MDGA2 HUWE1 LRP1B RALY IGF2BP3 CPEB4 ZFHX3 PATJ NIPBL EPB41L2 | 7.30e-04 | 1261 | 136 | 15 | EFO_0004338 |
| Disease | serum IgG glycosylation measurement | ARHGAP24 MDGA2 NAA50 LRP1B IGF2BP3 TMEM132D LUZP2 MARCOL EPB41L2 | 7.39e-04 | 523 | 136 | 9 | EFO_0005193 |
| Disease | nevus count, cutaneous melanoma | 8.46e-04 | 91 | 136 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | anthropometric measurement | 1.11e-03 | 168 | 136 | 5 | EFO_0004302 | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement | 1.13e-03 | 11 | 136 | 2 | EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.35e-03 | 12 | 136 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | metabolite measurement, body weight gain | 1.35e-03 | 12 | 136 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | anxiety disorder, stress-related disorder | 1.35e-03 | 12 | 136 | 2 | EFO_0006788, EFO_0010098 | |
| Disease | gallbladder cancer (is_implicated_in) | 1.59e-03 | 13 | 136 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | low affinity immunoglobulin gamma Fc region receptor III-B measurement | 1.85e-03 | 14 | 136 | 2 | EFO_0008212 | |
| Disease | Nasal Cavity Polyp | 2.11e-03 | 55 | 136 | 3 | EFO_1000391 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 2.13e-03 | 15 | 136 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 2.34e-03 | 57 | 136 | 3 | EFO_0022284 | |
| Disease | Polyposis, Adenomatous Intestinal | 2.43e-03 | 16 | 136 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 2.43e-03 | 16 | 136 | 2 | C2713443 | |
| Disease | cholesterol in IDL measurement | 2.46e-03 | 58 | 136 | 3 | EFO_0021899 | |
| Disease | total lipids in IDL | 2.71e-03 | 60 | 136 | 3 | EFO_0022161 | |
| Disease | sphingomyelin 14:0 measurement | 2.74e-03 | 17 | 136 | 2 | EFO_0010390 | |
| Disease | Adenomatous Polyposis Coli | 2.74e-03 | 17 | 136 | 2 | C0032580 | |
| Disease | free cholesterol in IDL measurement | 2.84e-03 | 61 | 136 | 3 | EFO_0022181 | |
| Disease | Bone marrow hypocellularity | 3.07e-03 | 18 | 136 | 2 | C1855710 | |
| Disease | hair color | 3.27e-03 | 311 | 136 | 6 | EFO_0003924 | |
| Disease | fat body mass | 3.39e-03 | 217 | 136 | 5 | EFO_0005409 | |
| Disease | forced expiratory volume | CACNA1D NCOA6 ARHGAP24 BMP2K ATAD5 RALY IGF2BP3 DST IGHMBP2 WDR41 | 3.66e-03 | 789 | 136 | 10 | EFO_0004314 |
| Disease | Microcephaly | 3.70e-03 | 67 | 136 | 3 | C0025958 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 3.74e-03 | 222 | 136 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | ovarian carcinoma | 3.82e-03 | 321 | 136 | 6 | EFO_0001075 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 4.02e-03 | 69 | 136 | 3 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | Parkinson disease | 4.59e-03 | 22 | 136 | 2 | cv:C0030567 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSKQLENQNPQGRQL | 1041 | Q14146 | |
| KQPQVKEGNNTNKSE | 381 | Q5TYW2 | |
| QSHQVDKQGVNSQKP | 1176 | Q96QE3 | |
| NKNLGPVTTAENKDQ | 2151 | A6H8Y1 | |
| ESFQNAQAGSNPKKV | 591 | Q92667 | |
| QLRKAAEQGQQDPNK | 106 | Q92870 | |
| PNGEAKESQSIGKQN | 526 | Q8IVF6 | |
| TNQHVKQNGKLEDNP | 116 | Q05D32 | |
| EAQQAQKSAEQPEQK | 861 | Q02952 | |
| NKQFSQLSSDPNNQK | 226 | Q86UK0 | |
| KQPQVKEGNNTNKSE | 381 | Q4UJ75 | |
| SQGKEKAVSNNVNPV | 561 | Q9UIF8 | |
| LNKAFSINKETQPGQ | 86 | Q86TY3 | |
| TINKQQNAESQGKAP | 61 | Q8N4X5 | |
| NSNPVSPQKQRAEKA | 251 | Q8N2N9 | |
| SATNKFLNPQKDGVN | 201 | Q9NSY1 | |
| QENGTANPIKNGKTS | 701 | Q9NSY1 | |
| ENQKNNPTLLENKSG | 411 | Q9Y222 | |
| KPTLSQQQKSPEQQE | 216 | Q14624 | |
| DKVSNPKTNGDSQQP | 126 | Q9UKX7 | |
| KDKAAQQQLQQDSGG | 221 | P43699 | |
| IRDTPAKNAQKSNQN | 196 | P06748 | |
| RNTKQKNDEKTPQGA | 71 | O95478 | |
| QNHSKKGADQQQPPQ | 396 | Q5TC82 | |
| QTSNVTNKNDPKSIN | 6 | Q86SE5 | |
| QASNVTNKNDPKSIN | 6 | Q9UKM9 | |
| GQPEPAKDQQQKAAQ | 611 | Q9NW13 | |
| VKNKEINSDQATQGN | 1216 | Q29RF7 | |
| DNSNQKQLKRPAQGK | 1086 | Q2KHR3 | |
| KKVNNGSNVENDIQQ | 1041 | Q9UPP5 | |
| AGNVKQQEKSQPSES | 91 | Q6NTE8 | |
| KQPQVKEGNNTNKSE | 381 | Q5SQ80 | |
| LQNGANPNQKDQKQK | 1241 | Q8N7Z5 | |
| SGQKKQQQSKPQGEA | 291 | P58215 | |
| DGSNSKILFQNQKEP | 1721 | Q9NZR2 | |
| VNAGNVIQQSAAKKG | 576 | P46199 | |
| AKAKVQQTPDGSQQS | 71 | P13196 | |
| QKTPSQQSNILDNGQ | 1331 | Q96NW7 | |
| PENSKTLATQLNQQK | 1321 | Q03001 | |
| QNSPAGNKENIKPNE | 756 | Q99700 | |
| KAQKQVQFNPGQTRA | 1821 | Q5SZK8 | |
| NQGTTALPKNKNQEG | 56 | Q53TS8 | |
| KPKEVAENQQNQSSD | 26 | O43491 | |
| QKNLKVPSGQNADVQ | 151 | Q9GZZ1 | |
| SQNGQQSQDVQKKET | 1081 | P56645 | |
| SNNPKTEKIKDQVNG | 301 | P34910 | |
| VSQSEENGQKPENKA | 151 | O96028 | |
| TNNAKNHSPKQLQEA | 746 | Q9H0H0 | |
| TKPNDNKQNNGRSET | 681 | Q6KC79 | |
| LISGKNPQIQNSNKP | 206 | Q8N8V2 | |
| PQKKGASKQDQSANE | 336 | P18505 | |
| GQQAQTQTGKQTEKN | 316 | Q8N752 | |
| QASQEKQQKENLGQA | 556 | O94927 | |
| KQNQGAAPEIQALKN | 621 | Q86VS8 | |
| PRLNKNSKNSNGQEL | 1686 | Q7Z6Z7 | |
| QTKFRQQPNAGKKQD | 866 | P16144 | |
| KQHQQQKALQSGPPQ | 561 | O00425 | |
| IANNNVGNPAKKSTN | 311 | Q7Z553 | |
| QQGLPKKQQQLEFQG | 466 | Q15646 | |
| RKNQLISFQNGTPKN | 261 | Q8NB91 | |
| GVNNKQNNTNANKPK | 901 | Q14686 | |
| QSVNKGKQGKEQNQD | 481 | Q8N573 | |
| QSKPQDGVSNNNEIQ | 336 | Q8N264 | |
| GQLQNKENNNTKDSP | 356 | Q8N264 | |
| KQPQVKEGNNTNKSE | 381 | Q5VUR7 | |
| KEQPQAKAGNGQNSC | 1981 | Q9ULT8 | |
| RNTGKSIANKNIANP | 311 | P51553 | |
| VGPRNSTNKNKNNAS | 1086 | Q6Y7W6 | |
| QVNFQEGQLNSGKKQ | 96 | P49454 | |
| ANKKNTATQETGPEN | 526 | Q14CM0 | |
| QQLGKNIKFGQRSPN | 41 | Q6ZU35 | |
| VNSQPVNEKDSNDKN | 666 | O75128 | |
| QSPQKQQTEKANSGN | 231 | Q5T1N1 | |
| SPNNKPKLNTGQIQE | 1096 | Q6IQ26 | |
| AAKSKPQQSASGNNE | 251 | Q86TE4 | |
| NSKKQTQDQQTEDQP | 596 | Q96JA4 | |
| AQEKKSPKGQFQNVQ | 611 | Q96JA4 | |
| GTSTPQAKNKNFEEN | 321 | Q8NA82 | |
| KQQNFGLNNATQPKK | 51 | Q5VTH9 | |
| ESPKQNSGKEQNDNT | 576 | Q96MM7 | |
| GSEKAKSQQQEQQDP | 76 | Q17RY0 | |
| QTKKQQQRQPEASIG | 386 | Q96AY2 | |
| EACKAAGQAPQQKTQ | 11 | A6NKP2 | |
| VQAVNEKNGENKTSP | 261 | Q7Z5N4 | |
| VNDKNGDNKTSQPIT | 186 | Q58EX2 | |
| IGKQVPTSTNANLNN | 1746 | Q01668 | |
| EPNVGSKQPKHINNN | 486 | Q6P995 | |
| QPESKTLQGSNTQQK | 36 | Q05469 | |
| AKTFHLVNPNGQKQQ | 481 | Q9Y2M0 | |
| KIQNNDNVGKPKSRS | 276 | Q08170 | |
| KKQDQPTFDNSGNIL | 676 | Q8WXH0 | |
| ANIKVKFGQNDANPN | 791 | Q14C87 | |
| AINAKRSKEKNPGNQ | 736 | Q5JRA6 | |
| VQATQSAQEKEKQGQ | 816 | P30414 | |
| NTQGELQNASPKQRK | 56 | Q8WVI7 | |
| NPDGSAQQQSKAVNK | 151 | Q9HCL2 | |
| LNQPGILKNSGKSNQ | 96 | A0A1B0GUY1 | |
| GKSNQKGNPESSNKQ | 106 | A0A1B0GUY1 | |
| DKNGEQKSQNNVLPK | 851 | Q7Z333 | |
| PPGAQEKEQDQVNNK | 121 | Q03519 | |
| KKSNNGTDVNAGQIP | 1366 | O75592 | |
| KQNDIIPGKNNLSNV | 291 | Q8IX21 | |
| EPSGKKQNKRVNNTD | 2031 | Q9P2P6 | |
| KPNPNQISVNNVKAG | 361 | Q13330 | |
| KQIANTKGNENANGA | 86 | Q9Y5B9 | |
| AQRKQATNNNEAKNG | 326 | Q8IZV5 | |
| ADKDVKNNNGQTPFQ | 371 | Q9Y566 | |
| PKSQDQDDIKNQQPA | 666 | Q0P6D6 | |
| NSEISGQMKQPLQAN | 2206 | P25054 | |
| QQDPKQENGAKNSNQ | 476 | Q9H9A5 | |
| KFPGDKSSTTQNNNQ | 316 | Q9NZN8 | |
| KSEGEQQLKPNNSNA | 6 | Q5JXX7 | |
| PATQNSANQNKEDTK | 981 | Q9HCE3 | |
| GNNPSKFVGQQLKCN | 156 | Q96PE6 | |
| KPQISAAQSTQPQKQ | 16 | Q5T6F2 | |
| NKVSGSQQQEKPASF | 661 | A0A0J9YY54 | |
| GSNVKLVCNVKANPQ | 136 | Q6UXZ0 | |
| QKGVPVKQNTAVNSS | 1116 | O14924 | |
| QNQSKKAEGAPNQGR | 206 | Q9P2E9 | |
| QNQGKKVDTTPNQGK | 266 | Q9P2E9 | |
| QNQAKKVEGAQNQGK | 296 | Q9P2E9 | |
| RQQKKDQDFPTAGQT | 36 | Q8NB66 | |
| KRQQKAQNANTTQDP | 1536 | O60673 | |
| NKTKGANQSQTPCVQ | 241 | P60508 | |
| IPNVHNKANKITGNQ | 1166 | Q8NI35 | |
| AKKRLGTNQENQQPN | 826 | O95235 | |
| GVDNNKNKGQLTKSP | 321 | Q16181 | |
| GQPASKEQQASGQQK | 846 | P38935 | |
| NQGEFQKPDNKLHQQ | 116 | Q9UKY0 | |
| ITPKTQGTNQIQKNT | 261 | Q8IX01 | |
| SKKGQKANNLNTPNN | 1136 | O60281 | |
| TVAGVPSQNNIQKSQ | 416 | Q9UKY1 | |
| TQTGEKPNNSNKCAV | 206 | Q13398 | |
| QQKQKQANGVVGNEA | 546 | Q9UGP8 | |
| SAQPPGNSQNIKRKQ | 21 | O95359 | |
| GNSQNIKRKQQDTPG | 26 | O95359 | |
| LKNADSQNGKDNPTT | 406 | Q16222 | |
| KQQPKQDSTEQGNAD | 21 | Q5HYM0 | |
| AATPSKDINQLQKAN | 236 | O15195 | |
| GNKEPLADTSSNQQK | 861 | P49750 | |
| KVNIPAKNNDQPQSA | 651 | P37275 | |
| NKSRTNAKGAPLNIN | 441 | Q92609 | |
| NAKGAPLNINKVSNS | 446 | Q92609 | |
| GQQKEKSDQQQVKQS | 21 | A0A075B6W5 | |
| NGKFQQSGQKLSIPQ | 276 | Q15238 | |
| NNQERKSPGVKNQGD | 1891 | P15822 | |
| SKQASQPVKKQQENA | 376 | Q9HAD4 | |
| GSNIKNFPQDNQKVR | 971 | Q8NFA0 | |
| NDFPANSGNNTKNKN | 601 | O95405 | |
| NSGNNTKNKNDILGK | 606 | O95405 | |
| KQEPNGNSKVNKAQE | 501 | Q8NBN3 | |
| DDAQKQPVKNQLGLN | 6 | P51522 | |
| NQTQEKQGQPKPELQ | 2441 | Q15911 | |
| PNQKTGHNLQVKNED | 176 | Q5VVJ2 |